Literature DB >> 12358748

alpha-Synuclein exhibits competitive interaction between calmodulin and synthetic membranes.

Daekyun Lee1, Sun-Young Lee, Eui-Nam Lee, Chung-Soon Chang, Seung R Paik.   

Abstract

alpha-Synuclein, a pathological component of Parkinson's disease by constituting the Lewy bodies, has been suggested to be involved in membrane biogenesis via induction of amphipathic alpha-helices. Since the amphipathic alpha-helix is also known as a recognition signal of calmodulin for its target proteins, molecular interaction between alpha-synuclein and calmodulin has been investigated. By employing a chemical coupling reagent of N-(ethoxycarbonyl)-2-ethoxy-1,2-dihydroquinoline, alpha-synuclein has been shown to yield a heterodimeric 1 : 1 complex with calmodulin on sodium dodecyl sulfate-polyacrylamide gel electrophoresis in the presence and even absence of calcium, whereas beta-synuclein was more dependent upon calcium for its calmodulin interaction. The selective calmodulin interaction of alpha-synuclein in the absence of calcium was also demonstrated with the aggregation kinetics of the synucleins in which only the alpha-synuclein aggregation was affected by calmodulin. A reversible binding assay confirmed that alpha-synuclein interacted with the Ca2+-free as well as the Ca2+-bound calmodulins with almost identical Kds of 0.35 micro m and 0.31 micro m, respectively, while beta-synuclein preferentially recognized the Ca2+-bound form with a Kd of 0.68 micro m. By using a C-terminally truncated alpha-synuclein of alpha-syn97, the calmodulin binding site(s) on alpha-synuclein was(were) shown to be located on the N-terminal region where the amphipathic alpha-helices have been suggested to be induced upon membrane interaction. By employing liposome and calmodulin in a state of being either soluble or immobilized on agarose, actual competition of alpha-synuclein between membranes and calmodulin was demonstrated with the observation that alpha-synuclein previously bound to the liposome was released upon specific interaction with the calmodulins. Taken together, these data may suggest that alpha-synuclein could act not only as a negative regulator for calmodulin in the presence and even absence of calcium, but it could also exert its activity at the interface between calmodulin and membranes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12358748     DOI: 10.1046/j.1471-4159.2002.01024.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  21 in total

1.  Calcineurin determines toxic versus beneficial responses to α-synuclein.

Authors:  Gabriela Caraveo; Pavan K Auluck; Luke Whitesell; Chee Yeun Chung; Valeriya Baru; Eugene V Mosharov; Xiaohui Yan; Manu Ben-Johny; Martin Soste; Paola Picotti; Hanna Kim; Kim A Caldwell; Guy A Caldwell; David Sulzer; David T Yue; Susan Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-13       Impact factor: 11.205

2.  Genetic association study between RIT2 and Parkinson's disease in a Han Chinese population.

Authors:  Jun-Ying Li; Jin-Hong Zhang; Nan-Nan Li; Ling Wang; Zhong-Jiao Lu; Lan Cheng; Xiao-Yi Sun; Rong Peng
Journal:  Neurol Sci       Date:  2016-11-26       Impact factor: 3.307

3.  Comparative analysis of different peptidyl-prolyl isomerases reveals FK506-binding protein 12 as the most potent enhancer of alpha-synuclein aggregation.

Authors:  Angélique Deleersnijder; Anne-Sophie Van Rompuy; Linda Desender; Hans Pottel; Luc Buée; Zeger Debyser; Veerle Baekelandt; Melanie Gerard
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

4.  Prolyl oligopeptidase enhances α-synuclein dimerization via direct protein-protein interaction.

Authors:  Mari H Savolainen; Xu Yan; Timo T Myöhänen; Henri J Huttunen
Journal:  J Biol Chem       Date:  2015-01-02       Impact factor: 5.157

5.  Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans.

Authors:  Rina Ved; Shamol Saha; Beth Westlund; Celine Perier; Lucinda Burnam; Anne Sluder; Marius Hoener; Cecilia Mp Rodrigues; Aixa Alfonso; Clifford Steer; Leo Liu; Serge Przedborski; Benjamin Wolozin
Journal:  J Biol Chem       Date:  2005-10-19       Impact factor: 5.157

6.  Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes.

Authors:  Worawan B Limpitikul; Ivy E Dick; Rosy Joshi-Mukherjee; Michael T Overgaard; Alfred L George; David T Yue
Journal:  J Mol Cell Cardiol       Date:  2014-05-08       Impact factor: 5.000

7.  NMR structure of calmodulin complexed to an N-terminally acetylated α-synuclein peptide.

Authors:  James M Gruschus; Thai Leong Yap; Sara Pistolesi; Alexander S Maltsev; Jennifer C Lee
Journal:  Biochemistry       Date:  2013-05-08       Impact factor: 3.162

8.  Beta-synuclein occurs in vivo in lipid-associated oligomers and forms hetero-oligomers with alpha-synuclein.

Authors:  Eitan Israeli; Ronit Sharon
Journal:  J Neurochem       Date:  2008-12-02       Impact factor: 5.372

9.  Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

Authors:  Nathan Pankratz; Gary W Beecham; Anita L DeStefano; Ted M Dawson; Kimberly F Doheny; Stewart A Factor; Taye H Hamza; Albert Y Hung; Bradley T Hyman; Adrian J Ivinson; Dmitri Krainc; Jeanne C Latourelle; Lorraine N Clark; Karen Marder; Eden R Martin; Richard Mayeux; Owen A Ross; Clemens R Scherzer; David K Simon; Caroline Tanner; Jeffery M Vance; Zbigniew K Wszolek; Cyrus P Zabetian; Richard H Myers; Haydeh Payami; William K Scott; Tatiana Foroud
Journal:  Ann Neurol       Date:  2012-03       Impact factor: 10.422

Review 10.  Complicity of α-synuclein oligomer and calcium dyshomeostasis in selective neuronal vulnerability in Lewy body disease.

Authors:  Kenji Yamamoto
Journal:  Arch Pharm Res       Date:  2021-06-10       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.